Live
- AI Model Detects Residual Brain Tumors in 10 Seconds, Offers Real-Time Surgical Guidance
- Reliance and Disney Complete JV Deal to Strengthen Entertainment Presence in India
- UP Govt Agrees to Protesters’ Demand, PCS Exam to Be Held in One Day
- Trump’s Social Security Tax Promise Faces Hurdles: What Retirees Need to Know
- Strict Action Needed Against Attacks on Government Employees - Retired Employees
- Hyundai Motor India Limited Announces 2024 Edition of ‘Hyundai Always Around’ Campaign
- Minister for Environment, Forests, and Endowments Celebrates Karthika Pournami and Guru Nanak Jayanti
- World Quality Day: Hindustan Zinc Reaffirms Commitment to Superior Product Quality & Innovation
- Grand Kartika Purnima Celebrations at Nagar Kurnool’s Saraswati Shishu Mandir
- Children’s day celebrations, Karnataka remnisences on Nehru’s contributions
Hyderabad doc enlightens Japanese on Ventricular Tachycardia
City-based Dr B Hygriv Rao, Director Pacing & Electrophysiology KIMS Hospitals received the honour of giving a lecture at the Asia Pacific Heart Rhythm society (APHRS) and Japanese Heart Rhythm society in Japan recently. Dr Rao spoke on ‘A structured protocol involving radiofrequency ablation’, which he designed.
City-based Dr B Hygriv Rao, Director Pacing & Electrophysiology KIMS Hospitals received the honour of giving a lecture at the Asia Pacific Heart Rhythm society (APHRS) and Japanese Heart Rhythm society in Japan recently. Dr Rao spoke on ‘A structured protocol involving radiofrequency ablation’, which he designed.
“Ventricular Tachycardia is a dangerous arrhythmia where the ventricles beat so rapidly that no effective cardiac pumping occurs. This rapid beating may lead to sudden death and a high energy shock needs to be administered to save the patient’s life. This is a life threatening condition which occurs in 10- 155 of patients who have a heart attack before and carries a mortality of 80 per cent,” informed the doctor.
A structured protocol involving radiofrequency ablation was designed by Dr Rao to treat such patients. Recognising this effort, Dr Rao was invited by the APHRS at the congress, which was attended by 5,000 delegates from USA, Europe and Asia. “It was a distinguished honour to discuss the treatment designed in India for this challenging clinical condition with world experts,” he said about the event.
